founded in 2015, is a clinical-stage biopharmaceutical company pioneering the development of host-cell-targeting therapies against viral infections.
Read more
Atriva Therapeutics GmbHChristian Pangratz+49 69 999916210lichtenberger@atriva-therapeutics.com